Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

University of Waterloo

$42,400.00

Development of microelectomechanical systems platform integrated with novel microwave technology and droplet-based microfluidic devices for high throughout screening

EF 2012-13

Résumé
Severe congestion and long waiting times in hospital and clinical diagnosis have been a never-ending battle in Canada and worldwide, which is largely due to the lack of inexpensive and efficient High Throughput Screening (HTS) technology. An ideal HTS technology will allow users to simultaneously investigate a sample for a large number of disease markers leading to a rapid and accurate conclusion on the patient's health condition. The emerging droplet-based microfluidics has the potential to realize an order of magnitude higher throughput (i.e. kHz) than the existing methods (up to ~ 10Hz) by utilizing monodisperse, fully compartmentalized droplets generated in such devices at a rate of kHz as test tubes. However, selective heating and manipulation of individual droplets (i.e. test tubes) which are essential for quantitative biomedical analysis have not been addressed in a way that the system is affordable to be implemented in a standard clinical setting. This project will develop a robust, inexpensive microelectromechanical systems (MEMS) platform that will enable reliable HTS for quantitative biomedical diagnosis by employing novel microwave technology for selective heating and manipulation of individual droplets in microfluidic devices. The development will build upon the team's early demonstration and expertise in microwave technology and droplet-based microfluidics and will heavily rely on the support from Advanced Electrophoresis Solution Ltd which is highly interested in commercializing the developed technology and platform by the end. The platform will enable statistically and clinically significant data on a large number of disease markers within a reasonable time window. This project will quantitatively demonstrate its efficiency by applying it to evaluate protein aggregation behavior, a very good indicator of Alzheimer's disease, versus temperature. The platform will, for the first time, realize an order of magnitude higher throughput screening for biomedical analysis and be affordable to a standard clinical setting. This project directly falls into the NSERC Strategic target area of MANUFACTURING for ""developing MEMS platform applicable to Microfluidics for biomedical instrumentation realization"".
Programme
Collaborative Research and Development Grants
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
428921-2011
Name nom
Ren, Carolyn
Department département
Mechanical Engineering and Mechatronics
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
42400
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
2109
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical systems and instrumentation
Research subject fr
Instrumentation et systèmes mécaniques
Partie
1
Nb partie
3
Application title
Development of microelectomechanical systems platform integrated with novel microwave technology and droplet-based microfluidic devices for high throughout screening
Keyword
NSERC
Application summary
Severe congestion and long waiting times in hospital and clinical diagnosis have been a never-ending battle in Canada and worldwide, which is largely due to the lack of inexpensive and efficient High Throughput Screening (HTS) technology. An ideal HTS technology will allow users to simultaneously investigate a sample for a large number of disease markers leading to a rapid and accurate conclusion on the patient's health condition. The emerging droplet-based microfluidics has the potential to realize an order of magnitude higher throughput (i.e. kHz) than the existing methods (up to ~ 10Hz) by utilizing monodisperse, fully compartmentalized droplets generated in such devices at a rate of kHz as test tubes. However, selective heating and manipulation of individual droplets (i.e. test tubes) which are essential for quantitative biomedical analysis have not been addressed in a way that the system is affordable to be implemented in a standard clinical setting. This project will develop a robust, inexpensive microelectromechanical systems (MEMS) platform that will enable reliable HTS for quantitative biomedical diagnosis by employing novel microwave technology for selective heating and manipulation of individual droplets in microfluidic devices. The development will build upon the team's early demonstration and expertise in microwave technology and droplet-based microfluidics and will heavily rely on the support from Advanced Electrophoresis Solution Ltd which is highly interested in commercializing the developed technology and platform by the end. The platform will enable statistically and clinically significant data on a large number of disease markers within a reasonable time window. This project will quantitatively demonstrate its efficiency by applying it to evaluate protein aggregation behavior, a very good indicator of Alzheimer's disease, versus temperature. The platform will, for the first time, realize an order of magnitude higher throughput screening for biomedical analysis and be affordable to a standard clinical setting. This project directly falls into the NSERC Strategic target area of MANUFACTURING for ""developing MEMS platform applicable to Microfluidics for biomedical instrumentation realization"".